-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
63049133092
-
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
-
Altekruse SF, McGlynn KA and Reichman ME: Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485-1491, 2009.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1485-1491
-
-
Altekruse, S.F.1
McGlynn, K.A.2
Reichman, M.E.3
-
3
-
-
47249128185
-
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004
-
DOI 10.1002/hep.22312
-
Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E and La Vecchia C: Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 48: 137-145, 2008. (Pubitemid 351980469)
-
(2008)
Hepatology
, vol.48
, Issue.1
, pp. 137-145
-
-
Bosetti, C.1
Levi, F.2
Boffetta, P.3
Lucchini, F.4
Negri, E.5
La, V.C.6
-
4
-
-
0028949002
-
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma
-
Adachi E, Maeda T, Matsumata T, et al: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108: 768-775, 1995.
-
(1995)
Gastroenterology
, vol.108
, pp. 768-775
-
-
Adachi, E.1
Maeda, T.2
Matsumata, T.3
-
6
-
-
0029024521
-
Nitric oxide synthase activity in human breast cancer
-
Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995.
-
(1995)
Br J Cancer
, vol.72
, pp. 41-44
-
-
Thomsen, L.L.1
Miles, D.W.2
Happerfield, L.3
Bobrow, L.G.4
Knowles, R.G.5
Moncada, S.6
-
7
-
-
0031984809
-
Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
-
Ambs S, Merriam WG, Bennett WP, et al: Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 58: 334-341, 1998. (Pubitemid 28047076)
-
(1998)
Cancer Research
, vol.58
, Issue.2
, pp. 334-341
-
-
Ambs, S.1
Merriam, W.G.2
Bennett, W.P.3
Felley-Bosco, E.4
Ogunfusika, M.O.5
Oser, S.M.6
Klein, S.7
Shields, P.G.8
Billiar, T.R.9
Harris, C.C.10
-
8
-
-
0034485823
-
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival
-
Ekmekcioglu S, Ellerhorst J, Smid CM, et al: Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 6: 4768-4775, 2000. (Pubitemid 32110418)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.12
, pp. 4768-4775
-
-
Ekmekcioglu, S.1
Ellerhorst, J.2
Smid, C.M.3
Prieto, V.G.4
Munsell, M.5
Buzaid, A.C.6
Grimm, E.A.7
-
9
-
-
24144500806
-
Abnormalities in nitric oxide and its derivatives in lung cancer
-
DOI 10.1164/rccm.200411-1523OC
-
Masri FA, Comhair SA, Koeck T, et al: Abnormalities in nitric oxide and its derivatives in lung cancer. Am J Respir Crit Care Med 172: 597-605, 2005. (Pubitemid 41232971)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.172
, Issue.5
, pp. 597-605
-
-
Masri, F.A.1
Comhair, S.A.A.2
Koeck, T.3
Xu, W.4
Janocha, A.5
Ghosh, S.6
Dweik, R.A.7
Golish, J.8
Kinter, M.9
Stuehr, D.J.10
Erzurum, S.C.11
Aulak, K.S.12
-
10
-
-
58149182297
-
Nitric oxide donors: Novel cancer therapeutics
-
Review
-
Huerta S, Chilka S and Bonavida B: Nitric oxide donors: novel cancer therapeutics (Review). Int J Oncol 33: 909-927, 2008.
-
(2008)
Int J Oncol
, vol.33
, pp. 909-927
-
-
Huerta, S.1
Chilka, S.2
Bonavida, B.3
-
11
-
-
0026076012
-
Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins
-
Shaulsky G, Goldfinger N and Rotter V: Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins. Cancer Res 51: 5232-5237, 1991.
-
(1991)
Cancer Res
, vol.51
, pp. 5232-5237
-
-
Shaulsky, G.1
Goldfinger, N.2
Rotter, V.3
-
12
-
-
79251609206
-
Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-kB/Snail/YY1/RKIP circuitry
-
Bonavida B and Baritaki S: Dual role of NO donors in the reversal of tumor cell resistance and EMT: downregulation of the NF-kB/Snail/YY1/RKIP circuitry. Nitric Oxide 24: 1-7, 2011.
-
(2011)
Nitric Oxide
, vol.24
, pp. 1-7
-
-
Bonavida, B.1
Baritaki, S.2
-
13
-
-
82355171937
-
Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: Role of chelatable iron
-
Hickok JR, Sahni S, Mikhed Y, Bonini MG and Thomas DD: Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron. J Biol Chem 286: 41413-41424, 2011.
-
(2011)
J Biol Chem
, vol.286
, pp. 41413-41424
-
-
Hickok, J.R.1
Sahni, S.2
Mikhed, Y.3
Bonini, M.G.4
Thomas, D.D.5
-
14
-
-
47049088507
-
Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastases
-
Bonavida B, Baritaki S, Huerta-Yepez S, Vega MI, Chatterjee D and Yeung K: Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. Nitric Oxide 19: 152-157, 2008.
-
(2008)
Nitric Oxide
, vol.19
, pp. 152-157
-
-
Bonavida, B.1
Baritaki, S.2
Huerta-Yepez, S.3
Vega, M.I.4
Chatterjee, D.5
Yeung, K.6
-
15
-
-
4944225542
-
Nitric oxide, a mediator of inflammation, suppresses tumorigenesis
-
DOI 10.1158/0008-5472.CAN-04-2201
-
Hussain SP, Trivers GE, Hofseth LJ, et al: Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res 64: 6849-6853, 2004. (Pubitemid 39330989)
-
(2004)
Cancer Research
, vol.64
, Issue.19
, pp. 6849-6853
-
-
Hussain, S.P.1
Trivers, G.E.2
Hofseth, L.J.3
He, P.4
Shaikh, I.5
Mechanic, L.E.6
Doja, S.7
Jiang, W.8
Subleski, J.9
Shorts, L.10
Haines, D.11
Laubach, V.E.12
Wiltrout, R.H.13
Djurickovic, D.14
Harris, C.C.15
-
16
-
-
20844449408
-
Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors
-
DOI 10.1073/pnas.0409581102
-
Le X, Wei D, Huang S, Lancaster JR Jr and Xie K: Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci USA 102: 8758-8763, 2005. (Pubitemid 40862808)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.24
, pp. 8758-8763
-
-
Le, X.1
Wei, D.2
Huang, S.3
Lancaster Jr., J.R.4
Xie, K.5
-
17
-
-
13844256586
-
Quantification of apolipoprotein E receptors in human brain-derived cell lines by real-time polymerase chain reaction
-
DOI 10.1016/j.neurobiolaging.2004.08.004
-
Thilakawardhana S, Everett DM, Murdock PR, Dingwall C and Owen JS: Quantification of apolipoprotein E receptors in human brain-derived cell lines by real-time polymerase chain reaction. Neurobiol Aging 26: 813-823, 2005. (Pubitemid 40249483)
-
(2005)
Neurobiology of Aging
, vol.26
, Issue.6
, pp. 813-823
-
-
Thilakawardhana, S.1
Everett, D.M.2
Murdock, P.R.3
Dingwall, C.4
Owen, J.S.5
-
18
-
-
69949097533
-
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery
-
Yang XR, Xu Y, Yu B, et al: CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res 15: 5518-5527, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5518-5527
-
-
Yang, X.R.1
Xu, Y.2
Yu, B.3
-
19
-
-
0034906314
-
Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: Possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases
-
Rahman MA, Dhar DK, Yamaguchi E, et al: Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res 7: 1325-1332, 2001. (Pubitemid 32708688)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.5
, pp. 1325-1332
-
-
Rahman, M..A.1
Dhar, D.K.2
Yamaguchi, E.3
Maruyama, S.4
Sato, T.5
Hayashi, H.6
Ono, T.7
Yamanoi, A.8
Kohno, H.9
Nagasue, N.10
-
20
-
-
0041742276
-
Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase
-
Wei D, Richardson EL, Zhu K, et al: Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res 63: 3855-3859, 2003. (Pubitemid 36917893)
-
(2003)
Cancer Research
, vol.63
, Issue.14
, pp. 3855-3859
-
-
Wei, D.1
Richardson, E.L.2
Zhu, K.3
Wang, L.4
Le, X.5
He, Y.6
Huang, S.7
Xie, K.8
-
21
-
-
77955740818
-
Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein
-
Sugita H, Kaneki M, Furuhashi S, Hirota M, Takamori H and Baba H: Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein. Mol Cancer Res 8: 1152-1163, 2010.
-
(2010)
Mol Cancer Res
, vol.8
, pp. 1152-1163
-
-
Sugita, H.1
Kaneki, M.2
Furuhashi, S.3
Hirota, M.4
Takamori, H.5
Baba, H.6
-
22
-
-
30544452870
-
Mutant p53 gain of function: Reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression
-
DOI 10.1038/sj.onc.1209026, PII 1209026
-
Bossi G, Lapi E, Strano S, Rinaldo C, Blandino G and Sacchi A: Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene 25: 304-309, 2006. (Pubitemid 43083692)
-
(2006)
Oncogene
, vol.25
, Issue.2
, pp. 304-309
-
-
Bossi, G.1
Lapi, E.2
Strano, S.3
Rinaldo, C.4
Blandino, G.5
Sacchi, A.6
|